From Casetext: Smarter Legal Research

In re Lalu

United States Court of Appeals, Federal Circuit
Nov 2, 1984
747 F.2d 703 (Fed. Cir. 1984)

Summary

finding two cases about a different legal issue and with different facts contained dicta that "[wa]s helpful as a guide"

Summary of this case from Kelly v. United States

Opinion

Appeal No. 83-1358.

November 2, 1984.

Brian M. Poissant, New York City, submitted for appellant.

Clyde C. Metzger, New York City, of counsel.

Joseph F. Nakamura, Sol., Jere W. Sears, Deputy Sol., Washington, D.C., and Henry W. Tarring, II, Associate Sol., Arlington, Va., submitted for appellee.

Appeal from the United States Patent and Trademark Office Board of Appeals.

Before BALDWIN, Circuit Judge, COWEN, Senior Circuit Judge, and KASHIWA, Circuit Judge.


This appeal is from a decision of the United States Patent and Trademark Office Board of Appeals (board) affirming the rejection under 35 U.S.C. § 103 of claims 13-22, all of the claims of appellants' application Serial No. 966,508, filed December 4, 1978, for "New Polyfluorinated Sulphonic Acids And Their Derivatives". We reverse.

The Invention

The invention relates to perfluoroalkyl sulfonyl chlorides and bromides having the formula:

C[n]F[2n]+[1](CH[2])[b]SO[2]Z

wherein the perfluoroalkyl group C[n]F[2n]+[1] is defined by n being a number between 1 and 20, Z is a chlorine or bromine atom, and the bridging group (CH[2])[b] is defined by b being a number between 2 and 20.

The claimed compounds are useful in the textile, leather, and paper industries. The compounds have utility as corrosion inhibiting agents, surface active agents, and leveling agents, and therefore can be incorporated into waxes, greases, varnishes, and paints to improve the spreading out and leveling of such viscous products.

Claim 13, the only independent claim on appeal, is illustrative:

13. A product having the formula C[n]F[2n]+[1](CH[2])[b]SO[2]Z wherein C[n]F[2n]+[1] represents a straight or branched perfluorinated hydrocarbon chain, n is a number between 1 and 20, b is a number between 2 and 20 and Z is a chlorine or bromine atom.

C[n]F[2n]+1CH[2]SO[2]C1

Claims 14-22 depend from claim 13 and further limit the parameters n, b, and Z which define the length of the perfluoroaklyl group, the length of the bridging group, and the nature of the Z halide group, i.e., a chlorine or bromine atom.

The Prior Art

The sole reference relied upon by the board is United States Patent No. 3,130,221 issued April 21, 1964 to Oesterling. Oesterling discloses 1,1-dihydroperfluoroalkyl sulfonic acids having the formula:

C[n]F[2n]+[1]CH[2]SO[3]H

Wherein C[n]F[2n + 1] is a lower perfluoroalkyl group and the bridging group is a methylene (CH[2]) group. According to Oesterling, "The compounds of this invention include the 1,1-dihydroperfluoroalkyl acids containing from two to five carbon atoms; i.e., from one to four carbon atoms in the * * * [perfluoroalkyl] portion of the molecule." These compounds are strong acids and are used in reactions such as base neutralization, alkylation catalysis, and metal cleaning. Additionally, the compounds are useful as high energy fuels such as liquid rocket propellants because of their relatively high thermal stability. Of the group of acids disclosed by Oesterling, "the preferred compound for use as a high energy fuel is 1,1-dihydroperfluoroethylsulfonic acid [CF[3]CH[2]SO[3]H]. As the number of carbon atoms in the molecule increases, the thermal stability decreases and compounds containing above five carbon atoms are of little value as a fuel."

The claimed sulfonic acids are prepared in the reference by chlorination of the corresponding bis (1,1-dihydroperfluoroalkyl) disulfides to form the corresponding 1,1-dihydroperfluoroalkyl sulfonyl chlorides, which are then hydrolyzed to produce the product 1,1-dihydroperfluoroalkyl sulfonic acids. The intermediate sulfonyl chlorides which are used to prepare the final product sulfonic acids have the formula: wherein C[n]F[2n + 1] is also a lower perfluoroalkyl group and the bridging group is a methylene (CH[2]) group. Oesterling teaches that the hydrolysis may be carried out without isolation of the intermediate sulfonyl chloride, but it is preferable to hydrolyze isolated sulfonyl chloride in order to obtain a purer sulfonic acid product.

The Rejection

The examiner rejected the claims based on structural obviousness because Oesterling teaches homologous compounds. The examiner said, "Oesterling discloses only one method of preparing the sulfonic acids which requires the use of the halide intermediate. One motivated to prepare the homologous acids would similarly be motivated to prepare the homologous acids halides." (emphasis in original).

The board, in affirming the examiner's rejection, said the close structural similarity between the reference sulfonyl chloride compounds and the claimed compounds was sufficient to raise the presumption of obviousness. The board said further:

The fact that the reference teaches that the sulfonyl chloride compounds are useful as an intermediate or a starting compound for the production of a corresponding sulfonic acid as opposed to the appellants' disclosure that the claimed compounds have other utilities does not by itself rebut the prima facie case of obviousness made out by the Examiner. * * * The case of In re Stemniski, 58 CCPA 1410, 444 F.2d 581, 170 USPQ 343 (1971), is distinguishable since here Oesterling discloses a utility (a starting material for making an acid) for the pertinent sulfonyl chlorides, whereas in Stemniski the reference disclosed no utility for the relevant compound. In view of the unequivocal identification and isolation of the sulfonyl chloride by Oesterling and the specific utility taught for the compound, a starting material for the preparation of a useful acid, the portions of the court's decision in In re Gyurik, 596 F.2d 1012, 201 USPQ 552 (CCPA 1979), relied upon by the appellants are not considered to dictate reversal of the Examiner's holding.

OPINION

Appellants argue that the acid taught by Oesterling is limited to a maximum of five carbon atoms and, therefore, there would be no motivation for one of ordinary skill to prepare an acid, or its predecessor sulfonyl chloride containing more than five carbon atoms. Accordingly, appellants contend that since their compounds may contain up to forty carbon atoms, they are not structurally similar to the Oesterling intermediate sulfonyl chlorides. We disagree with appellants' contentions because the Oesterling teachings regarding the five carbon atom limitation are related only to the use of the product acid as a high energy fuel. Oesterling discloses other uses for the disclosed sulfonic acids, such as in base neutralization, alkylation catalysis, and metal cleaning, to which the teachings of a five carbon atom limitation do not necessarily apply. Moreover, even if the compounds disclosed by Oesterling are limited to compounds containing two to five carbon atoms, the appellants' compounds contain as few as three carbon atoms.

We are, however, persuaded that the board erred in its conclusion of prima facie obviousness.

In determining whether a case of prima facie obviousness exists, it is necessary to ascertain whether the prior art teachings would appear to be sufficient to one of ordinary skill in the art to suggest making the claimed substitution or other modification. In re Taborsky, 502 F.2d 775, 780, 183 USPQ 50, 55 (CCPA 1974). The prior art must provide one of ordinary skill in the art the motivation to make the proposed molecular modifications needed to arrive at the claimed compound. In re Stemniski, 444 F.2d 581, 586, 170 USPQ 343, 347 (CCPA 1971), Taborsky, 502 F.2d at 781, 183 USPQ at 55, In re Murch, 464 F.2d 1051, 59 CCPA 1277, 175 USPQ 89 (1972), In re Fay, 347 F.2d 597, 52 CCPA 1483, 146 USPQ 47 (1965).

In Stemniski, the claimed compounds were rejected over structurally closely related compounds disclosed in prior art references. The references did not disclose or suggest any usefulness or significant properties, whereas the applicant disclosed a use for the claimed compounds in his application.

In such a case the court reasoned that the requisite motivation to make the claimed compounds would not be present. The court doubted whether a prima facie case of obviousness existed:

How can there be obviousness of structure, or particularly of the subject matter as a whole, when no apparent purpose or result is to be achieved, no reason or motivation to be satisfied, upon modifying the reference compounds' structure? Where the prior art reference neither discloses nor suggests a utility for certain described compounds, why should it be said that a reference makes obvious to one of ordinary skill in the art an isomer, homolog or analog of related structure, when that mythical, but intensely practical, person knows of no "practical" reason to make the reference compounds, much less any structurally related compounds?

444 F.2d at 586, 170 USPQ at 347.

Appellants argue that since several utilities were disclosed for the compounds claimed, and Oesterling teaches no significant properties or utility for the disclosed sulfonyl chlorides except as intermediates in the formation of the product sulfonic acids, the rejection of the instant claims is not proper in view of Stemniski. The Patent and Trademark Office (PTO) contends that Stemniski is satisfied and the rejection is proper because Oesterling discloses that the sulfonyl chlorides are used as intermediates or starting materials for producing useful acids.

The PTO further argues that the disclosed utility for the Oesterling sulfonyl chlorides as an intermediate for producing useful acids is a usefulness conforming with statutory guidelines, but cites cases for support which are actually in apposite: Reiners v. Mehltretter, 236 F.2d 418, 421-22, 43 CCPA 1019, 1023-26, 111 USPQ 97, 100 (1956), an interference in which structural obviousness was not an issue, and In re Kirk, 376 F.2d 936, 943-44, 54 CCPA 1119, 1126-28, 153 USPQ 48, 54 (1967), a case dealing with appellants' disclosure of "how to use" the claimed compounds under 35 U.S.C. § 112.

Other cases involving obviousness have dealt with the role of intermediates. In In re Gyurik, 596 F.2d 1012, 201 USPQ 552 (CCPA 1979), the claimed thio compounds were rejected as prima facie obvious over a reference which generally disclosed such thio compounds as intermediates in the preparation of the corresponding sulfonyl compounds having the same general properties as those of the claimed compounds. The issue framed by the court was based solely upon the status of the claimed compounds as intermediates in the production of end products specifically named in the prior art.

In reversing the obviousness rejection the court said:

An element in determining obviousness of a new chemical compound is the motivation of one having ordinary skill in the art to make it. That motivation is not abstract, but practical, and is always related to the properties or uses one skilled in the art would expect the compound to have, if made. In re Stemniski . . . . The present obviousness rejection cannot stand without some basis in the expected properties of the claimed compounds.

In obviousness rejections based on close similarity in chemical structure, the necessary motivation to make a claimed compound, and thus the prima facie case of obviousness, rises from the expectation that compounds similar in structure will have similar properties. * * * No common-properties presumption rises from the mere occurrence of a claimed compound at an intermediate point in a conventional reaction yielding a specifically named prior art compound. That an intermediate/end-product relationship exists between a claimed compound and a prior art compound does not alone create a common-properties presumption. Absent that presumption or other evidence of motivation, it cannot be said that it would have been obvious to stop the process for synthesizing the disclosed end product and isolate the claimed intermediate.[14] [Citations omitted.]

[14] The mere ability of a compound to act as an intermediate toward the production of other compounds does not alone constitute the sort of "property" that the cases on obviousness of chemical compounds contemplated.

Id. at 1018, 201 USPO at 557-8.

The court explained footnote 14 of Gyurik in In re Magerlein, 602 F.2d 366, 373 n. 15, 202 USPQ 473, 479 n. 15 (CCPA 1979):

Our recent statement . . . should not be read out of context as suggesting that the capacity to react to produce another compound is not, ipso facto, a property. The statement is merely a recognition that there is no common-properties presumption or evidence of motivation to make the intermediate from the mere fact that an intermediate is in the chain of production of another compound. [Emphasis added.]

Although Gyurik was not a case of obviousness based on structural similarity, and the facts of both Gyurik and Magerlein are different from those here, the dicta in those cases is helpful as a guide.

The PTO places great emphasis on the label "useful", contending that because the Oesterling final product is "useful", the intermediate sulfonyl chlorides are also "useful". That there is no common-properties presumption accorded to an intermediate and the end product of the reaction involving that intermediate necessarily means that there is no presumption that an intermediate's utility would be the same as that of the end product. Even if an unspecified "usefulness" or utility were all Stemniski requires, such utility could not be imputed from the fact that the Oesterling final product is "useful". The use of such labels, however, is meaningless because we always look to "the subject matter as a whole" in determining whether the subject matter "would have been obvious at the time the invention was made." Further, a relevant property of a compound cannot be ignored in the determination of non-obviousness. In re Papesch 315 F.2d 381, 391, 50 CCPA 1084, 1097, 137 USPQ 43, 51 (1963).

Ultimately our analysis of the obviousness or nonobviousness of appellants' claimed compounds requires inquiry as to whether there is anything in the Oesterling reference which would suggest the expected properties of the claimed compounds or whether Oesterling discloses any utility for the intermediate sulfonyl chlorides which would support an expectation that the claimed compounds would have similar properties.

There is no disclosure that the Oesterling compounds would have any properties in common with those of appellants' compounds, as those properties of the former relate to the use of the compounds for base neutralization, catalysis, metal cleaning, and fuel. The mere fact that Oesterling's sulfonyl chlorides can be used as intermediates in the production of the corresponding sulfonic acids does not provide adequate motivation for one of ordinary skill in the art to stop the Oesterling synthesis and investigate the intermediate sulfonyl chlorides with an expectation of arriving at appellants' claimed sulfonyl halides for use as corrosion inhibiting agents, surface active agents, or leveling agents.

Oesterling does not teach the isolation and investigation of the intermediate sulfonyl chlorides, but rather discloses, as an optional step, the isolation and purification of the intermediate to obtain a purer sulfonic acid end product. The isolation and subsequent use of the intermediate sulfonyl chlorides in the production of the corresponding useful sulfonic acids is not motivation sufficient to support the structural obviousness rejection. The board has therefore failed to properly establish that the claimed compounds would have been prima facie obvious in view of Oesterling.

The decision of the board affirming the rejection of claims 13-22 is reversed.

REVERSED


Summaries of

In re Lalu

United States Court of Appeals, Federal Circuit
Nov 2, 1984
747 F.2d 703 (Fed. Cir. 1984)

finding two cases about a different legal issue and with different facts contained dicta that "[wa]s helpful as a guide"

Summary of this case from Kelly v. United States
Case details for

In re Lalu

Case Details

Full title:IN RE JEAN PIERR LALU AND LOUIS FOULLETIER

Court:United States Court of Appeals, Federal Circuit

Date published: Nov 2, 1984

Citations

747 F.2d 703 (Fed. Cir. 1984)

Citing Cases

In re Dillon

[Emphasis in original.] (quoting Lindemann Maschinenfabrik GmbH, 730 F.2d at 1462, 221 USPQ at 488); In re…

Genetics Inst. Llc v. Vaccines

” (emphasis added)); In re Grabiak, 769 F.2d 729, 731–32 (Fed.Cir.1985) (To establish prima facie…